[Skip to Content]
[Skip to Content Landing]
Other Articles
July 1, 1950


JAMA. 1950;143(9):831. doi:10.1001/jama.1950.02910440049028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The following statement has been prepared for The Journal of the American Medical Association because of the large number of inquiries from physicians, clinics and hospitals as to the distribution of pituitary adrenocorticotropic hormone (ACTH) as the quantity available becomes larger. We would appreciate the cooperation of The Journal in informing the medical profession as to the situation; this statement is offered only for this purpose.In formulating a policy regarding the distribution of ACTH and education in its use, the company has consulted with an advisory committee, which included the following physicians: Dr. George Thorn, Harvard Medical School, Boston; Dr. J. S. L. Browne, McGill University, Montreal, Canada; Dr. Robert Loeb, College of Physicians and Surgeons, New York; Dr. Walter Bauer, Harvard Medical School, Boston; Dr. A. McGehee Harvey, Johns Hopkins University, Baltimore; Dr. Randall Sprague, Mayo Clinic, Rochester, Minn.; Dr. Philip Hench, Mayo Clinic, Rochester,

First Page Preview View Large
First page PDF preview
First page PDF preview